4//SEC Filing
Vizirgianakis Stavros G. 4
Accession 0001235802-22-000122
CIK 0001453593other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:19 PM ET
Size
5.4 KB
Accession
0001235802-22-000122
Insider Transaction Report
Form 4
Vizirgianakis Stavros G.
Director
Transactions
- Award
Common Stock, $0.000001 par value
2022-11-15+144,639→ 5,995,355 total
Footnotes (2)
- [F1]These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Second Amended and Restated 2018 Equity Incentive Plan, (as amended from time to time, the "2018 Equity Plan"), and vest and become issuable on August 15, 2023, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
- [F2]Includes 215,415 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the 2018 Equity Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001559834
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:19 PM ET
- Size
- 5.4 KB